Iridex Corp (IRIX) Stock Price, Quote & News

Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems th...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 940 4700

Fax: 650 940 4710

Website: www.iridex.com

Address:

1212 Terra Bella Avenue, Mountain View, United States

StudBull Aug. 16 at 5:50 PM

$IRIX I’m hoping we’ll see more insider buying from Moore et al with the window now open. That would be consistent with the Q2 gross margin draw down being more a one time event than a new normal

1 · Reply

StudBull Aug. 12 at 11:15 PM

$IRIX comments about Q2 earnings call. Parts 2/3 and 3/3 are provided in thread

1 · Reply

StudBull Aug. 12 at 8:59 PM

$IRIX Total Revenue of 13.6M, up +7.4% YoY and +14.1% vs Q1 https://iridex.gcs-web.com/news-releases/news-release-details/iridex-reports-second-quarter-2025-financial-results

1 · Reply

StudBull Aug. 12 at 8:07 PM

$IRIX please baby please baby please baby, baby baby please

0 · Reply

10baggerPete Aug. 12 at 3:32 PM

$IRIX showtime 😎

1 · Reply

StudBull Jul. 27 at 3:15 PM

$IRIX I think @finance_schmidt 's new report on Iridex is a must read for anyone following this company/stock. It's available (free) via his Trident Opportunities Substack account https://x.com/finance_schmidt/status/1948474005138055204

0 · Reply

Stock_Catcher Jul. 25 at 1:39 PM

$IRIX vol

0 · Reply

StudBull Jul. 22 at 11:05 PM

$IRIX Finally closed above the 200 day MA

0 · Reply

deerix Jul. 18 at 3:00 PM

$IRIX nobody gave a shit about this one. Guess we win alone

1 · Reply

Paraboljoker Jul. 17 at 4:08 PM

$IRIX 👀

0 · Reply

IRIDEX Corporation (IRIX) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:05 PM EDT - 5 days ago

Iridex Reports Second Quarter 2025 Financial Results

Jun 24, 2025, 7:00 AM EDT - 7 weeks ago

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

May 13, 2025, 9:05 PM EDT - 3 months ago

IRIDEX Corporation, Inc. (IRIX) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:05 PM EDT - 3 months ago

Iridex Reports First Quarter 2025 Financial Results

May 1, 2025, 6:00 PM EDT - 3 months ago

IRIDEX Changes Course

Apr 30, 2025, 4:05 PM EDT - 3 months ago

Iridex to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 16, 2025, 7:11 PM EDT - 4 months ago

IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript)

Apr 9, 2025, 4:05 PM EDT - 4 months ago

Iridex to Host Strategic Vision Call on April 16, 2025

Mar 27, 2025, 6:03 PM EDT - 5 months ago

IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 4:05 PM EDT - 5 months ago

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 19, 2025, 9:15 AM EDT - 5 months ago

Iridex Announces Strategic Investment in the Company

Mar 14, 2025, 7:00 AM EDT - 5 months ago

Iridex Comments on Recent Stock Price Volatility

Mar 13, 2025, 5:00 PM EDT - 5 months ago

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Dec 18, 2024, 4:05 PM EST - 8 months ago

Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

Nov 19, 2024, 8:14 AM EST - 9 months ago

Iridex Comments on Changing Glaucoma Reimbursement Landscape

Nov 16, 2024, 3:53 PM EST - 9 months ago

IRIDEX Corporation (IRIX) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 10 months ago

Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024

Oct 3, 2024, 4:05 PM EDT - 11 months ago

Iridex Appoints Patrick Mercer as Chief Executive Officer

Aug 26, 2024, 11:16 AM EDT - 1 year ago

Iridex Frustrates, But Expect A Transaction By Year-End

Aug 10, 2024, 4:23 PM EDT - 1 year ago

IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript

May 17, 2024, 3:27 PM EDT - 1 year ago

IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:05 PM EDT - 1 year ago

Iridex Reports First Quarter 2024 Financial Results

Mar 28, 2024, 7:12 PM EDT - 1 year ago

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

Mar 26, 2024, 7:30 PM EDT - 1 year ago

IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 4:05 PM EDT - 1 year ago

Iridex Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 20, 2024, 4:05 PM EDT - 1 year ago

Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024

Jan 24, 2024, 8:00 AM EST - 1 year ago

Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust

Jan 11, 2024, 6:45 PM EST - 1 year ago

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

Dec 28, 2023, 6:00 PM EST - 1 year ago

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

Nov 27, 2023, 9:00 AM EST - 1 year ago

Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation

Nov 14, 2023, 4:21 PM EST - 1 year ago

Iridex Reports Third Quarter 2023 Financial Results and Business Update

Nov 13, 2023, 9:00 AM EST - 1 year ago

Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023

Nov 2, 2023, 6:11 AM EDT - 1 year ago

Iridex Reimbursement Chaos Presents Buying Opportunity

Oct 26, 2023, 4:22 PM EDT - 1 year ago

Iridex to Report Third Quarter Financial Results on November 14, 2023

Oct 4, 2023, 5:04 AM EDT - 2 years ago

Iridex: The Whole Is Less Than The Sum Of The Parts

Aug 29, 2023, 4:05 PM EDT - 2 years ago

Iridex Announces Strategic Review to Unlock Shareholder Value

Aug 10, 2023, 8:33 PM EDT - 2 years ago

IRIDEX Corporation (IRIX) Q2 2023 Earnings Call Transcript

Apr 27, 2023, 4:05 PM EDT - 2 years ago

Iridex to Report First Quarter Financial Results on May 11, 2023

Mar 9, 2023, 10:12 PM EST - 2 years ago

IRIDEX Corporation (IRIX) Q4 2022 Earnings Call Transcript

Mar 9, 2023, 4:05 PM EST - 2 years ago

Iridex Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 7, 2023, 4:05 PM EST - 2 years ago

Iridex to Present at the 35th Annual Roth Conference

Mar 2, 2023, 9:00 AM EST - 2 years ago

Iridex Introduces New Research and Showcases Five Events at the AGS Meeting

Feb 23, 2023, 4:05 PM EST - 2 years ago

Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023

Jan 10, 2023, 4:05 PM EST - 2 years ago

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022

Dec 6, 2022, 5:07 PM EST - 2 years ago

Iridex to Participate in Fireside Chat with Stifel Equity Research

Nov 10, 2022, 10:11 PM EST - 3 years ago

IRIDEX Corporation (IRIX) Q3 2022 Earnings Call Transcript

Sep 29, 2022, 4:05 PM EDT - 3 years ago

Iridex Showcases its Non-Incisional Treatments for Glaucoma, Introduces Sweep Management Software, and Hosts 8 Physician Presentations at AAO 2022

Aug 18, 2022, 4:05 PM EDT - 3 years ago

Iridex to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Aug 15, 2022, 6:55 PM EDT - 3 years ago

IRIDEX Corporation's (IRIX) CEO David Bruce on Q2 2022 Results - Earnings Call Transcript

StudBull Aug. 16 at 5:50 PM

$IRIX I’m hoping we’ll see more insider buying from Moore et al with the window now open. That would be consistent with the Q2 gross margin draw down being more a one time event than a new normal

1 · Reply

StudBull Aug. 12 at 11:15 PM

$IRIX comments about Q2 earnings call. Parts 2/3 and 3/3 are provided in thread

1 · Reply

StudBull Aug. 12 at 8:59 PM

$IRIX Total Revenue of 13.6M, up +7.4% YoY and +14.1% vs Q1 https://iridex.gcs-web.com/news-releases/news-release-details/iridex-reports-second-quarter-2025-financial-results

1 · Reply

StudBull Aug. 12 at 8:07 PM

$IRIX please baby please baby please baby, baby baby please

0 · Reply

10baggerPete Aug. 12 at 3:32 PM

$IRIX showtime 😎

1 · Reply

StudBull Jul. 27 at 3:15 PM

0 · Reply

Stock_Catcher Jul. 25 at 1:39 PM

$IRIX vol

0 · Reply

StudBull Jul. 22 at 11:05 PM

$IRIX Finally closed above the 200 day MA

0 · Reply

deerix Jul. 18 at 3:00 PM

$IRIX nobody gave a shit about this one. Guess we win alone

1 · Reply

Paraboljoker Jul. 17 at 4:08 PM

$IRIX 👀

0 · Reply

alexpitti Jul. 17 at 3:33 PM

$IRIX up 15% today why

1 · Reply

StudBull Jul. 17 at 2:58 PM

$IRIX

0 · Reply

deerix Jul. 17 at 2:52 PM

$IRIX I post things nobody is looking at ggs. Remember what happened to $OPEN and $VOR Either way that's 25% since post over 30 since entry.

1 · Reply

deerix Jul. 16 at 8:17 PM

$IRIX again everyone is asleep. Zzz

1 · Reply

investingworlds Jul. 10 at 6:44 AM

$IRIX is this stock gone? Looks like everyone just gave up on this.

1 · Reply

deerix Jul. 9 at 12:25 PM

$IRIX IRIX watch: Q2 earnings ~Aug 14, UK DAME trial unfolding H2 updates & move toward cash‑flow breakeven. Insiders (CFO & director) just bought ~47K shares (~$198K)—strong vote of confidence 👀🚀

0 · Reply

ricericebaby111 Jul. 7 at 4:06 PM

Exited my position in $IRIX and put it into $GKPRF. I do not like the company increasing the share count from 30 million to 100 million. I do not like voting in of current board members who allowed the stock to crash from $3 to under $1. The new CEO has done an excellent job turning the company around, but they are definitely not out of the woods. They could have been extremely profitable years ago if they had just stuck to the Retina business. The constant spending on Glaucoma has screwed all of us over and its time for me to move on to something extremely more promising. Especially with the 8 new contract wins that $GKPRF recently received.

0 · Reply

deerix Jul. 7 at 2:15 PM

$IRIX again no eyes on this, oh well what can I say

0 · Reply

deerix Jul. 2 at 3:40 PM

$IRIX added some at 0.92

0 · Reply

investingworlds Jun. 28 at 5:16 PM

$IRIX what do you all think of the amended change in the strike price of options from $1.40 to $0.94? Never seen an amendment like rhat before.

1 · Reply

StudBull Jun. 26 at 5:43 PM

$IRIX Anyone have any idea why this stock is tanking?

2 · Reply

StudBull Jun. 24 at 1:20 PM

$IRIX https://www.stocktitan.net/news/IRIX/iridex-announces-first-patient-enrolled-in-an-independent-landmark-t2ilwbrgc6wt.html

0 · Reply

Market Cap	19.20M
Revenue (ttm)	48.67M
Net Income (ttm)	-8.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-18.31%
Debt to Equity Ratio	0.53

Volume	35,300
Avg Vol	122,854
Day's Range	N/A - N/A
Shares Out	16.99M
Stochastic %K	22%
Beta	0.62
Analysts	Strong Buy
Price Target	$2.00